Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2019 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair

SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...
March 06, 2019 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Selected as Finalist for Cancer Innovation Award

SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
February 04, 2019 12:25 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces Award of Canadian Patent

SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the...
October 10, 2018 12:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Licenses CyPath® Lung to Precision Pathology Services

SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued...
July 31, 2018 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Welcomes Mohsin Y. Meghji to Board of Directors

SAN ANTONIO, July 31, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Mohsin...
May 14, 2018 10:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors

SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S....
March 01, 2018 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Joins Early Detection Research Network

SAN ANTONIO, March 01, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has been approved for membership in the Early Detection...
November 29, 2017 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Welcomes New Board Members

SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
March 09, 2017 19:02 ET | Source: bioAffinity Technologies, Inc.

City of San Antonio Invests in bioAffinity Technologies

SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...
November 15, 2016 09:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces Award of Hong Kong Patent

SAN ANTONIO, Nov. 15, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard...